BioWorld

June 25, 2007

View Archived Issues

Targeted Genetics Adds $19.5M To Bank In Private Placement

Gene therapy firm Targeted Genetics Corp. is boosting its cash position through a $19.5 million private placement of 6.7 million shares priced at $2.91 each to fund ongoing development activities. (BioWorld Today) Read More

Dios Looking Upstream Of TNF For Autoimmune Disease Target

Read More

Got A New Formulation? But, That's So Obvious!

Read More

Distinct Mechanisms For Boron's Anticancer, Anti-Infective Effects

Read More

Other News To Note

Read More